Document Detail


Cyclic AMP regulates the expression and nuclear translocation of RFC40 in MCF7 cells.
MedLine Citation:
PMID:  16413017     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have previously shown that the regulatory subunit of PKA, RIalpha, functions as a nuclear transport protein for the second subunit of the replication factor C complex, RFC40, and that this transport appears to be crucial for cell cycle progression from G1 to S phase. In this study, we found that N(6)-monobutyryl cAMP significantly up-regulates the expression of RFC40 mRNA by 1.8-fold and its endogenous protein by 2.3-fold with a subsequent increase in the RIalpha-RFC40 complex formation by 3.2-fold. Additionally, the nuclear to cytoplasmic ratio of RFC40 increased by 26% followed by a parallel increase in the percentage of S phase cells by 33%. However, there was reduction in the percentage of G1 cells by 16% and G2/M cells by 43% with a concurrent accumulation of cells in S phase. Interestingly, the higher percentage of S phase cells did not correlate with a parallel increase in DNA replication. Moreover, although cAMP did not affect the expression of the other RFC subunits, there was a significant decrease in the RFC40-37 complex formation by 81.3%, substantiating the decrease in DNA replication rate. Taken together, these findings suggest that cAMP functions as an upstream modulator that regulates the expression and nuclear translocation of RFC40.
Authors:
Rakhee S Gupte; Valerie Sampson; Frank Traganos; Zbigniew Darzynkiewicz; Marietta Y W T Lee
Related Documents :
15638327 - Boromycin abrogates bleomycin-induced g2 checkpoint.
1655277 - The retinoblastoma gene product regulates progression through the g1 phase of the cell ...
6692397 - Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-d-arabinofuranosy...
498067 - Response of 9l tumor cells in vitro to spirohydantoin mustard.
10906147 - The identification of a nonclassical cadherin expressed during b cell development and i...
24440277 - Specific aquaporins facilitate nox-produced hydrogen peroxide transport through plasma ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-01-17
Journal Detail:
Title:  Experimental cell research     Volume:  312     ISSN:  0014-4827     ISO Abbreviation:  Exp. Cell Res.     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-03-20     Completed Date:  2006-05-16     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  0373226     Medline TA:  Exp Cell Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  796-806     Citation Subset:  IM    
Affiliation:
Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Active Transport, Cell Nucleus / physiology
Cell Line, Tumor
Cell Nucleus / drug effects,  metabolism*
Cyclic AMP / pharmacology,  physiology*
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
Cyclic AMP-Dependent Protein Kinases / drug effects,  metabolism
DNA Replication / drug effects
Dose-Response Relationship, Drug
Gene Expression Regulation / drug effects,  genetics
Humans
Replication Protein C / drug effects,  genetics*,  metabolism*
S Phase / drug effects
Transcription, Genetic / genetics
Tumor Cells, Cultured
Up-Regulation
Grant Support
ID/Acronym/Agency:
GM31973/GM/NIGMS NIH HHS; R01 CA028704-27/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; 0/PRKAR1A protein, human; 0/RFC2 protein, human; 0/Replication Protein C; 60-92-4/Cyclic AMP; EC 2.7.11.11/Cyclic AMP-Dependent Protein Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-der...
Next Document:  PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells...